Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days

New feature: Introducing the Finviz Matrix

mdxhealth

Contributing Author

Recent Articles by mdxhealth

Aug-13	Mdxhealth Reports Second Quarter 2026 Financial Results MDXH MDXH +74.89% GlobeNewswire
Jul-30	Mdxhealth to Release Second Quarter 2026 Financial Results on August 13 MDXH GlobeNewswire
Jul-24	Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency MDXH GlobeNewswire
Jul-02	Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency MDXH -6.02% GlobeNewswire
Jun-29	Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial MDXH -6.28% GlobeNewswire
May-13	Mdxhealth Reports Q1-2026 Results MDXH MDXH -49.50% GlobeNewswire
Apr-30	Mdxhealth to Release First Quarter 2026 Financial Results on May 13 MDXH GlobeNewswire
Mar-16	Mdxhealth Highlights Data from Oxford's ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026 MDXH +5.31% GlobeNewswire
Feb-26	Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results MDXH GlobeNewswire
Feb-12	Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 MDXH GlobeNewswire
Jan-12	MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences MDXH +5.21% GlobeNewswire
Jan-06	Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer MDXH GlobeNewswire
Nov-12	Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025 MDXH -7.42% GlobeNewswire
Nov-03	Mdxhealth to Release Third Quarter 2025 Financial Results on November 12 MDXH GlobeNewswire
Sep-15	Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne MDXH GlobeNewswire
Aug-05	Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne MDXH MDXH +10.44% GlobeNewswire
Jul-03	Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change MDXH GlobeNewswire
May-14	MDxHealth Reports Q1-2025 Results MDXH MDXH +6.74% GlobeNewswire

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)